Lytix Biopharma presents fourth quarter and second half 2022 results ...Middle East

PR Newswire - News
OSLO, Norway, Feb. 16, 2023 /PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, today releases its fourth quarter and second half 2022 results - Steady progress towards improving cancer treatment outcomes. "Our molecules have a...

Hence then, the article about lytix biopharma presents fourth quarter and second half 2022 results was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lytix Biopharma presents fourth quarter and second half 2022 results )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News